APO RESEARCH · REPORT
Continuous Glucose Monitoring Systems
A continuous glucose monitoring (CGM) system may help in these cases. The system consists of a small disposable sensor inserted into the skin, a transmitter connected to the sensor by a sensor mount wirelessly transmits results to a receiver and displays results.
Product & engineering
Understand the product.
A continuous glucose monitoring (CGM) system may help in these cases. The system consists of a small disposable sensor inserted into the skin, a transmitter connected to the sensor by a sensor mount wirelessly transmits results to a receiver and displays results.
Selected research
Market Structure
Global Continuous Glucose Monitoring Systems Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
A continuous glucose monitoring (CGM) system may help in these cases. The system consists of a small disposable sensor inserted into the skin, a transmitter connected to the sensor by a sensor mount wirelessly transmits results to a receiver and displays results.
Global Continuous Glucose Monitoring Systems key players include Dexcom, Abbott Laboratories, Medtronic, etc. Global top three manufacturers hold a share about 95%.
North America is the largest market, with a share about 65%, followed by Europe and Asia-Pacific, both have a share about 30 percent.
Read the full market overview
In terms of product, Wearable is the largest segment, with a share about 99%. And in terms of application, the largest application is Adult, followed by Elderly.
This report provides an overview of the global Continuous Glucose Monitoring Systems market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Continuous Glucose Monitoring Systems and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Continuous Glucose Monitoring Systems sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Continuous Glucose Monitoring Systems market size, projected growth trends, production technologies, key applications, and end-use industries.
Continuous Glucose Monitoring Systems Segment by Company
Dexcom
Abbott Laboratories
Medtronic
Senseonics Holdings
GlySens Incorporated
Meiqi Medical Equipment
San Meditech
Continuous Glucose Monitoring Systems Segment by Type
Wearable
Implantable
Continuous Glucose Monitoring Systems Segment by End Users
Child
Adult
Elderly
Continuous Glucose Monitoring Systems Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Continuous Glucose Monitoring Systems market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Continuous Glucose Monitoring Systems and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Continuous Glucose Monitoring Systems.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Continuous Glucose Monitoring Systems market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Continuous Glucose Monitoring Systems manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Continuous Glucose Monitoring Systems in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Continuous Glucose Monitoring Systems in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Wearable
- Implantable
Applications
- Child
- Adult
- Elderly
Companies covered
- Dexcom
- Abbott Laboratories
- Medtronic
- Senseonics Holdings
- GlySens Incorporated
- Meiqi Medical Equipment
- San Meditech
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Continuous Glucose Monitoring Systems Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Continuous Glucose Monitoring Systems Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global Continuous Glucose Monitoring Systems Sales Estimates and Forecasts (2021-2032)
- 1.5 Global Continuous Glucose Monitoring Systems Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global Continuous Glucose Monitoring Systems Market Dynamics
- 2.1 Continuous Glucose Monitoring Systems Industry Trends
- 2.2 Continuous Glucose Monitoring Systems Industry Drivers
- 2.3 Continuous Glucose Monitoring Systems Industry Opportunities and Challenges
- 2.4 Continuous Glucose Monitoring Systems Industry Restraints
3 Continuous Glucose Monitoring Systems Market by Manufacturers
- 3.1 Global Continuous Glucose Monitoring Systems Revenue by Manufacturers (2021-2026)
- 3.2 Global Continuous Glucose Monitoring Systems Sales by Manufacturers (2021-2026)
- 3.3 Global Continuous Glucose Monitoring Systems Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global Continuous Glucose Monitoring Systems Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Continuous Glucose Monitoring Systems Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Continuous Glucose Monitoring Systems Manufacturers, Product Type & Application
- 3.7 Global Continuous Glucose Monitoring Systems Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Continuous Glucose Monitoring Systems Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Continuous Glucose Monitoring Systems Players Market Share by Revenue in 2025
- 3.8.3 2025 Continuous Glucose Monitoring Systems Tier 1, Tier 2, and Tier 3
4 Continuous Glucose Monitoring Systems Market by Type
- 4.1 Continuous Glucose Monitoring Systems Type Introduction
- 4.1.1 Wearable
- 4.1.2 Implantable
- 4.2 Global Continuous Glucose Monitoring Systems Sales by Type
- 4.2.1 Global Continuous Glucose Monitoring Systems Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Continuous Glucose Monitoring Systems Sales by Type (2021-2032)
- 4.2.3 Global Continuous Glucose Monitoring Systems Sales Market Share by Type (2021-2032)
- 4.3 Global Continuous Glucose Monitoring Systems Revenue by Type
- 4.3.1 Global Continuous Glucose Monitoring Systems Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Continuous Glucose Monitoring Systems Revenue by Type (2021-2032)
- 4.3.3 Global Continuous Glucose Monitoring Systems Revenue Market Share by Type (2021-2032)
5 Continuous Glucose Monitoring Systems Market by Application
- 5.1 Continuous Glucose Monitoring Systems Application Introduction
- 5.1.1 Child
- 5.1.2 Adult
- 5.1.3 Elderly
- 5.2 Global Continuous Glucose Monitoring Systems Sales by Application
- 5.2.1 Global Continuous Glucose Monitoring Systems Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Continuous Glucose Monitoring Systems Sales by Application (2021-2032)
- 5.2.3 Global Continuous Glucose Monitoring Systems Sales Market Share by Application (2021-2032)
- 5.3 Global Continuous Glucose Monitoring Systems Revenue by Application
- 5.3.1 Global Continuous Glucose Monitoring Systems Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Continuous Glucose Monitoring Systems Revenue by Application (2021-2032)
- 5.3.3 Global Continuous Glucose Monitoring Systems Revenue Market Share by Application (2021-2032)
6 Global Continuous Glucose Monitoring Systems Sales by Region
- 6.1 Global Continuous Glucose Monitoring Systems Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Continuous Glucose Monitoring Systems Sales by Region (2021-2032)
- 6.2.1 Global Continuous Glucose Monitoring Systems Sales by Region (2021-2026)
- 6.2.2 Global Continuous Glucose Monitoring Systems Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Continuous Glucose Monitoring Systems Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Continuous Glucose Monitoring Systems Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Continuous Glucose Monitoring Systems Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Continuous Glucose Monitoring Systems Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Continuous Glucose Monitoring Systems Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Continuous Glucose Monitoring Systems Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa Continuous Glucose Monitoring Systems Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa Continuous Glucose Monitoring Systems Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global Continuous Glucose Monitoring Systems Revenue by Region
- 7.1 Global Continuous Glucose Monitoring Systems Revenue by Region
- 7.1.1 Global Continuous Glucose Monitoring Systems Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global Continuous Glucose Monitoring Systems Revenue by Region (2021-2026)
- 7.1.3 Global Continuous Glucose Monitoring Systems Revenue by Region (2027-2032)
- 7.1.4 Global Continuous Glucose Monitoring Systems Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America Continuous Glucose Monitoring Systems Revenue (2021-2032)
- 7.2.2 North America Continuous Glucose Monitoring Systems Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe Continuous Glucose Monitoring Systems Revenue (2021-2032)
- 7.3.2 Europe Continuous Glucose Monitoring Systems Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific Continuous Glucose Monitoring Systems Revenue (2021-2032)
- 7.4.2 Asia-Pacific Continuous Glucose Monitoring Systems Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa Continuous Glucose Monitoring Systems Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa Continuous Glucose Monitoring Systems Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 Dexcom
- 8.1.1 Dexcom Company Information
- 8.1.2 Dexcom Business Overview
- 8.1.3 Dexcom Continuous Glucose Monitoring Systems Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 Dexcom Continuous Glucose Monitoring Systems Product Portfolio
- 8.1.5 Dexcom Recent Developments
- 8.2 Abbott Laboratories
- 8.2.1 Abbott Laboratories Company Information
- 8.2.2 Abbott Laboratories Business Overview
- 8.2.3 Abbott Laboratories Continuous Glucose Monitoring Systems Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 Abbott Laboratories Continuous Glucose Monitoring Systems Product Portfolio
- 8.2.5 Abbott Laboratories Recent Developments
- 8.3 Medtronic
- 8.3.1 Medtronic Company Information
- 8.3.2 Medtronic Business Overview
- 8.3.3 Medtronic Continuous Glucose Monitoring Systems Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.3.4 Medtronic Continuous Glucose Monitoring Systems Product Portfolio
- 8.3.5 Medtronic Recent Developments
- 8.4 Senseonics Holdings
- 8.4.1 Senseonics Holdings Company Information
- 8.4.2 Senseonics Holdings Business Overview
- 8.4.3 Senseonics Holdings Continuous Glucose Monitoring Systems Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.4.4 Senseonics Holdings Continuous Glucose Monitoring Systems Product Portfolio
- 8.4.5 Senseonics Holdings Recent Developments
- 8.5 GlySens Incorporated
- 8.5.1 GlySens Incorporated Company Information
- 8.5.2 GlySens Incorporated Business Overview
- 8.5.3 GlySens Incorporated Continuous Glucose Monitoring Systems Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.5.4 GlySens Incorporated Continuous Glucose Monitoring Systems Product Portfolio
- 8.5.5 GlySens Incorporated Recent Developments
- 8.6 Meiqi Medical Equipment
- 8.6.1 Meiqi Medical Equipment Company Information
- 8.6.2 Meiqi Medical Equipment Business Overview
- 8.6.3 Meiqi Medical Equipment Continuous Glucose Monitoring Systems Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.6.4 Meiqi Medical Equipment Continuous Glucose Monitoring Systems Product Portfolio
- 8.6.5 Meiqi Medical Equipment Recent Developments
- 8.7 San Meditech
- 8.7.1 San Meditech Company Information
- 8.7.2 San Meditech Business Overview
- 8.7.3 San Meditech Continuous Glucose Monitoring Systems Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.7.4 San Meditech Continuous Glucose Monitoring Systems Product Portfolio
- 8.7.5 San Meditech Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Continuous Glucose Monitoring Systems Value Chain Analysis
- 9.1.1 Continuous Glucose Monitoring Systems Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Continuous Glucose Monitoring Systems Production Mode & Process
- 9.2 Continuous Glucose Monitoring Systems Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Continuous Glucose Monitoring Systems Distributors
- 9.2.3 Continuous Glucose Monitoring Systems Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst